미국의 요양시설 및 신경 재활 시장 규모, 점유율 및 동향 분석 보고서 : 성별, 연령별, 지역별, 지역별, 부문별 예측(2023-2030년)

U.S. Assisted Living Facility & Neurorehabilitation Market Growth & Trends:

The U.S. assisted living facility and neurorehabilitation market size is expected to reach USD 177.3 billion by 2030, registering a CAGR of 5.4% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increasing awareness, the desire of consumers to age in home-based services, and an increasing number of Traumatic Brain Injury (TBI) survivors seeking residential care post-neuro-rehab are the major factors driving the growth of the market. In addition, the lower cost of ALFs as compared to nursing homes will propel the market.

The growing geriatric population in need of a supportive environment and continuous care will fuel the growth of the market. According to the U.S. Census Bureau, by 2030, all baby boomers will be older than 65 years. According to the Rural Health Information Hub, 78.0 million people will be 65 years or older by 2030 and this number is expected to rise to 90.0 million by 2050. Presently, the highest number of assisted living facilities is in the west part of the country and they are accounted for about 40.0% of all assisted living facilities in the U.S. Furthermore, there is a high tendency of retirees moving to this region in the U.S. owing to a warm and sunny climate, availability of new and comfortable housing styles, and rising recreational opportunities. This is expected to propel the market in this particular region.

U.S. Assisted Living Facility & Neurorehabilitation Market Report Highlights:

• By gender, women held the maximum share in 2022 and the segment is predicted to exhibit the fastest growth over the forecast period. This can be attributed to the greater life expectancy of women and higher rates of disability and chronic health problems
• On the basis of age, the more than 85 years segment dominated the market in 2022. This segment is expected to expand at the fastest pace through 2030
• Increasing regulations on ALFs to ensure proper care and coordinated services could restrain the growth of the market. In the U.S., state-level regulation is enforced for licensing and certification and may vary in different states
• Strategic initiatives undertaken by various market players are expected to keep growth prospects upbeat in the following years
• Rising incidence of TBI drives the market for neurorehabilitation facilities. These patients are often discharged from ALFs based on the duration of treatment
• Competition in the market is very high and strict regulations and licensing are expected to pose barriers for new entrants.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Gender
  • 1.1.2. Age
  • 1.1.3. Country scope
  • 1.1.4. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
• 1.5. Market Formulation & Validation
• 1.6. Model Details
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Gender outlook
  • 2.2.2. Age outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Assisted Living Facility And Neurorehabilitation Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Market Dynamics
  • 3.3.1. Market Driver Analysis
  • 3.3.2. Market Restraint Analysis
• 3.4. U.S. Assisted Living Facility And Neurorehabilitation Market Analysis Tools
  • 3.4.1. Industry Analysis - Porter's
    • 3.4.1.1. Supplier power
    • 3.4.1.2. Buyer power
    • 3.4.1.3. Substitution threat
    • 3.4.1.4. Threat of new entrant
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Technological landscape
    • 3.4.2.3. Economic Landscape

Chapter 4. U.S. Assisted Living Facility And Neurorehabilitation: Gender Estimates & Trend Analysis

• 4.1. U.S. Assisted Living Facility And Neurorehabilitation Market: Key Takeaways
• 4.2. U.S. Assisted Living Facility And Neurorehabilitation Market: Movement & Market Share Analysis, 2022 & 2030
• 4.3. Women
  • 4.3.1. Women market estimates and forecasts, 2018 to 2030 (USD Billion)
• 4.4. Men
  • 4.4.1. Men market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 5. U.S. Assisted Living Facility And Neurorehabilitation: Age Estimates & Trend Analysis

• 5.1. U.S. Assisted Living Facility And Neurorehabilitation Market: Key Takeaways
• 5.2. U.S. Assisted Living Facility And Neurorehabilitation Market: Movement & Market Share Analysis, 2022 & 2030
• 5.3. More than 85
  • 5.3.1. More than 85 market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.4. 75-84
  • 5.4.1. 75-84 market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.5. 65-74
  • 5.5.1. 65-74 market estimates and forecasts, 2018 to 2030 (USD Billion)
• 5.6. Less than 65
  • 5.6.1. Less than 65 market estimates and forecasts, 2018 to 2030 (USD Billion)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Market Participant Categorization
  • 6.2.1. Centre For Neuro Skills
    • 6.2.1.1. Company overview
    • 6.2.1.2. Financial performance
    • 6.2.1.3. Product benchmarking
    • 6.2.1.4. Strategic initiatives
  • 6.2.2. Mary Lee Foundation
    • 6.2.2.1. Company overview
    • 6.2.2.2. Financial performance
    • 6.2.2.3. Product benchmarking
    • 6.2.2.4. Strategic initiatives
  • 6.2.3. NeuroRestorative
    • 6.2.3.1. Company overview
    • 6.2.3.2. Financial performance
    • 6.2.3.3. Product benchmarking
    • 6.2.3.4. Strategic initiatives
  • 6.2.4. The MENTOR Network
    • 6.2.4.1. Company overview
    • 6.2.4.2. Financial performance
    • 6.2.4.3. Product benchmarking
    • 6.2.4.4. Strategic initiatives
  • 6.2.5. Pate Rehabilitation
    • 6.2.5.1. Company overview
    • 6.2.5.2. Financial performance
    • 6.2.5.3. Product benchmarking
    • 6.2.5.4. Strategic initiatives
  • 6.2.6. ResCare, Inc.
    • 6.2.6.1. Company overview
    • 6.2.6.2. Financial performance
    • 6.2.6.3. Product benchmarking
    • 6.2.6.4. Strategic initiatives
  • 6.2.7. Texas NeuroRehab Center
    • 6.2.7.1. Company overview
    • 6.2.7.2. Financial performance
    • 6.2.7.3. Product benchmarking
    • 6.2.7.4. Strategic initiatives
  • 6.2.8. Texas Rehabilitation and Habilitation Specialists, LLC
    • 6.2.8.1. Company overview
    • 6.2.8.2. Financial performance
    • 6.2.8.3. Product benchmarking
    • 6.2.8.4. Strategic initiatives
  • 6.2.9. Moody Neurorehabilitation Institute
    • 6.2.9.1. Company overview
    • 6.2.9.2. Financial performance
    • 6.2.9.3. Product benchmarking
    • 6.2.9.4. Strategic initiatives